Saioa Goñi Irigoyen-rekin lankidetzan egindako argitalpenak (11)

2014

  1. Splicing regulator SLU7 is essential for maintaining liver homeostasis

    Journal of Clinical Investigation, Vol. 124, Núm. 7, pp. 2909-2920

2011

  1. Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation

    Hepatology, Vol. 54, Núm. 6, pp. 2149-2158

  2. Epidermal growth factor receptor (EGFR) crosstalks in liver cancer

    Cancers, Vol. 3, Núm. 2, pp. 2444-2461

2010

  1. Impairment of pre-mRNA splicing in liver disease: Mechanisms and consequences

    World Journal of Gastroenterology, Vol. 16, Núm. 25, pp. 3091-3102

  2. Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2-/- Mice

    PLoS ONE, Vol. 5, Núm. 12

2009

  1. Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors

    Gastroenterology, Vol. 137, Núm. 5

  2. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 29-37

  3. The epidermal growth factor receptor: A link between inflammation and liver cancer

    Experimental Biology and Medicine

  4. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy

    Cancer Research, Vol. 69, Núm. 4, pp. 1358-1367

2008

  1. Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury

    Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Núm. 1, pp. 9-18

  2. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis

    Hepatology, Vol. 48, Núm. 4, pp. 1251-1261